Synthetic protein switches for regulating target protein activity through site-specific phosphorylation

Background

The field of synthetic biology relies heavily on the ability to precisely control protein function in response to specific cellular states. Intracellular signaling networks, particularly those driven by endogenous kinase activity, dictate critical cellular behaviors like growth and apoptosis. There is a profound need for tools that can directly interface with these endogenous pathways to provide rapid, reversible, and post-translational control over target proteins. Such capabilities are essential for advancing targeted cell therapies, enabling high-throughput drug screening, and manipulating complex signaling dynamics within living tissues.

Despite this need, current approaches for regulating protein activity face significant limitations. Traditional kinase activity reporters are strictly observational; they utilize conformational changes merely to alter fluorophore distances without modulating actual biological functions. Meanwhile, existing engineered control systems predominantly rely on exogenous triggers like light or chemical inducers, failing to autonomously respond to internal cellular cues. When researchers harness natural response mechanisms, such as endogenous promoters, they encounter severe specificity issues and extensive crosstalk with off-target pathways. Furthermore, attempts to engineer synthetic allosteric switches using traditional flexible linkers often suffer from high “leaky” background activity and poor dynamic range.

Technology

This synthetic protein switch technology utilizes engineered allostery to precisely regulate target protein activity through site-specific phosphorylation. The modular architecture consists of a phosphorylatable substrate peptide, a phospho-binding domain, and an optimized hinge region. When a specific endogenous kinase phosphorylates the substrate, the binding domain interacts with it, triggering a conformational change. This structural shift allosterically modulates the function of an integrated target protein, such as a transcription factor or nanobody. The platform allows researchers to easily exchange components to target different kinases and control various cellular outputs.

This solution is differentiated by its systematic optimization, converting traditional FRET-based sensors into highly effective allosteric switches with a wide dynamic range. Unlike FRET sensors that use flexible linkers, this technology employs short, rigid helical sequences to maintain an inactive state and minimize background activity. Precise mutational tuning of the binding domain further eliminates “leaky” residual activity, achieving a greater than 20-fold change in output. Compared to traditional promoters, these switches offer superior specificity with minimal signaling crosstalk. Ultimately, this platform advances beyond chemically-gated systems by directly interfacing with endogenous intracellular signaling networks for rapid, reversible post-translational control.

Benefits

• Enables precise, rapid, and reversible control of protein function in response to endogenous cellular signals (kinase activity).
• Delivers high sensitivity and a wide dynamic range (over 20-fold change) with minimal background “leakiness” through the use of optimized rigid helical hinges.
• Provides superior signaling specificity with minimal crosstalk between different cellular pathways compared to traditional promoter-based methods.
• Features a highly modular design, allowing components to be easily swapped to target different kinases and regulate various proteins, such as transcription factors or nanobodies.
• Includes a generalizable toolkit (QCTK) that facilitates the rapid and efficient assembly of custom switch variants.
• Facilitates advanced applications across high-throughput drug screening, engineered cell therapies, and high-resolution biological research.

Applications

• Kinase inhibitor drug discovery
• Programmable cell therapy development
• Intracellular kinase activity biosensors
• Programmable synthetic biology circuits
• Oncogenic kinase targeted therapeutics

Additional info

This modular platform utilizes engineered allostery to regulate protein activity via site-specific phosphorylation. It integrates a substrate peptide, a phospho-binding domain, and rigid helical EAAAK hinges. Kinase-mediated phosphorylation triggers a conformational shift, allosterically toggling the function of fused targets like transcription factors or nanobodies. Optimized for high dynamic range and low background, the system enables precise, reversible control over endogenous signaling pathways like ERK or JNK.